Glioma invasion - Pattern of dissemination by mechanisms of invasion and surgical intervention, pattern of gene expression and its regulatory control by tumorsuppressor p53 and proto-oncogene ETS-1

Acta Neurochirurgica, Supplementum

Volumn , Issue 88, 2003, Pages 153-162

  Giese, A ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Ets 1; Glioma; Invasion; Migration; P53

Indexed keywords

ETS1 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR ETS 1;

ANIMAL; APOPTOSIS; ARTICLE; BRAIN; BRAIN TUMOR; CANCER INVASION; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; HUMAN; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; BRAIN; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1542682591     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6090-9_21     Document Type: Review

References (62)

1. Ala-aho R, Grenman R, Seth P, Kahari VM (2002) Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells. Oncogene 21: 1187-1195
2. Annegers JF, Laws ER, Kurland LT, Grabow JD (1979) Head trauma and subsequent brain tumors. Neurosurg 4: 203-206
3. Anzil AP (1970) Glioblastoma multiforme with extracranial metastasis in the absence of previous craniotomy. J Neurosurg 33: 88-94
4. Arita N, Taneda M, Hayakawa T (1994) Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome. Acta Neurochir (Wien) 126: 84-92
5. Aswad I, Bay J, Rogers L (1986) Leptomeningeal metastasis from supra tentorial malignant gliomas. Neurosurg 19: 247-251
6. Aupperle KR, Boyle DL, Hendrix M, Seftor EA, Zvaifler NJ, Barbosa M, Firestein GS (1998) Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol 152: 1091-1098
7. Batzdorf U, Golg V (1974) Dispersion of central nervous system tumors. Correlation between clinical aspects and tissue culture studies. J Neurosurg 41: 691-698
8. Behrens P, Rothe M, Florin A, Wellmann A, Wernert N (2001) Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression. Int J Mol Med 8: 149-154
9. Bernstein JJ, Getz R, Jefferson M, Kelemen M (1985) Astrocytes secrete basal lamina after hemisection of rat spinal cord. Brain Res 327: 135-141
10. Burger PC, Dubois PJ, Schold SC, Smith KR, Odom GL, Crafts DC, Giangaspero F (1983) Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58: 159-169
11. Elliott PJ, Keles GE, Waite M, Temkin N, Berger MS (1994) Ventricular entry during resection of malignant gliomas: effect on intracranial cerebrospinal fluid tumor dissemination. J Neurosurg 80:834-839
12. Erlich SS, Davis RL (1978) Spinal subarachnoid metastasis from primary intracranial glioblastoma multiforme. Cancer 42: 2854-2864
13. Giese A, Rief MD, Loo MA et al. (1994) Determinants of human astrocytoma migration. Cancer Res 54: 3897-3904
14. Giese A, Loo MA, Rief MD et al (1995) Substrates for astrocytoma invasion. Neurosurgery 37:294-302
15. Giese A, Kluwe L, Laube B et al (1996a) Migration of human glioma cells on myelin. Neurosurgery 38: 755-764
16. Giese A, Loo MA, Tran N el al (1996b) Dichotomy of astrocytoma migration and proliferation. Int J Cancer 67: 275-282
17. Giese A, Westphal M (1996c) Glioma invasion in the central nervous system. Neurosurgery 39:235-252
18. Giese A, Loo MA, Norman SA, Treasurywala S, Berens ME (1996d) Contrasting migratory effects of tenascin mediated by different integrins. J Cell Sei 109: 1-8
19. Giese A, Laube B, Zapf S et al (1998) Differential glioma cell adhesion and migration on human brain sections. Anticancer Res 18:2435-2448
20. Giese A, Hagel C, Kim EL et al (1999) Thromboxane synthase regulates the migratory phenotype of human glioma cells. NeuroOncology 1: 3-13
21. Giese A, Bjerkvig R, Berens ME, Westphal M (2003) The cost of migration-invasion of malignant gliomas and implications for treatment. J Clin Oncol (in press)
22. Grabb PA, Albright AL, Pang D (1992) Dissemination of su-pratentorial malignant gliomas via the cerebrospinal fluid in children. Neurosurg 30: 64-71
23. Kaczmarek E, Zapf S, Bouterfa H et al (1999) Dissecting glioma invasion: interrelation of adhesion, Migration and intercellular contacts determine the invasive phenotype. Int J Devi Neurosci 17:625-641
24. Kim EL, Günther W, Yoshizato K, Meissner H, Zapf S, Nüsing RM, Yamamoto H, Van Nleir E, Deppert W, Giese A. Tumor suppressor p53 inhibits transcriptional activation of the invasion gene thromboxane synthase mediated by the proto-oncogenic factor Ets-1. Oncogene (in press)
25. Kita D, Takino T, Nakada M, Takahashi T, Yamashita J, Sato H (2001) Expression of dominant-negative form of Ets-I suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin alpha5 expression in U251 glioma cell line. Cancer Res 61: 7985-7991
26. Kitange G, Kishikawa M, Nakayama T, Naito S, Iseki M, Shi-bata S (1999) Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors. Mod Pathol 12:618-626
27. Kitange G, Tsunoda K, Anda T, Nakamura S, Yasunaga A, Naito S, Shibata S (2000) Immunohistochemical expression of Ets-1 transcription factor and the urokinase-type plasminogen activator is correlated with the malignant and invasive potential in meningiomas. Cancer 89: 2292-2300
28. Kürzel F, Hagel C, Zapf S, Meissner H, Westphal M, Giese A (2002) Cyclooxygenase inhibitors and Thromboxane synthase inhibitors differentially regulate Migration arrest, Proliferation, and Apoptosis in human glioma cells. Acta Neurochir (Wien) 144:71-87
29. Kunz C, Pebler S, Otte J, von der Ahe D (1995) Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53. Nucleic Acids Res 23: 3710-3737
30. Loging WT, Reisman D (1999) Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53. Oncogene 18: 7608-7615
31. Mariani L, Beaudry C, McDonough WS et al (2001a) Glioma cell motility is associated with reduced transcription of pro-apoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncology 53: 161-176
32. Mariani L, McDonough WS, Hoelzinger DB, Beaudry C, Kaczmarek E, Coons SW, Giese A, Berens ME (2001b) Identification and validation of P311 as a glioblastoma invasion gene using laser capture microdissection. Cancer Res 61:4190-4196
33. Mariani L, Beaudry C, McDonough WS el al (2001c) Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro. J Clin Cancer Res 7: 2480-2489
34. Matsukado Y, MacCarty CS, Kernohan JW (1961) The growth of glioblastoma multiforme in neurosurgical practice. J Neurosurg 18: 636-644
35. McComb RD, Moul JM, Bigner DD (1987) Distribution of type VI collagen in human gliomas: comparison with fibronectin and glioma-mesenchymal matrix glycoprotein. J Neuropathol Exp Neurol 46: 623-633
36. McDonough W, Tran N, Giese A et al (1998) Altered gene expression in human astrocytoma cells selected for migration: I Thromboxane synthase. J Neuropath Exp Neurol 55:449-455
37. Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, Levine AJ, George DL (1999) Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev 13: 2490-2501
38. Nakada M, Yamashita J, Okada Y, Sato H (1999) Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of. astrocytic tumors. J Neuro-pathol Exp Neurol 58: 329-334
39. Nakopoulou L, Panayotopoulou EG, Giannopoulou I, Alexan-drou P, Katsarou S, Athanassiadou P, Keramopoulos A (2002) Stromelysin-3 protein expression in invasive breast cancer: relation to proliferation, cell survival and patients' outcome. Mod Pathol 15: 1154-1161
40. Obermann HA, Hewitt WC, Kalivoda AJ (1963) Medullo-blastoma with distant metastasis. Am J Clin Pathol 39:148-160
41. Ostertag B, Buschmann H (1941) Wie weit kann Wehrdienstbeschädigung bei Geschwulsten angenommen werden? Med Klein 37: 351-353
42. Ostertag B (1944) Der Contre-Coup am Splenium und die Frage der posttraumatischen Gliomentstehung. Monatsschr Unfallheilk 51:10-19
43. Pande P, Mathur M, Shukla NK, Raihan R (1999) Ets-1: a plausible marker of invasive potential and lymph node metastasis in human oral squamous cell carcinomas. J Pathol 189:40-45
44. Parker HL, Kernohan JW (1931) The relation of injury and glioma of the brain. JAMA 97: 535-540
45. Pastorcic M, Das HK (2000) Regulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogene. J Biol Chem 275: 34938-34945
46. Ridet J-L, Malhotra SK, Privat A, Gage FH (1997) Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20: 570-577
47. Rubinstein LJ (1967) Development of extracranial metastasis from a malignant astrocytoma in the absence of previous craniotomy: Case report. J Neurosurg 26: 542-547
48. Rutka JT, Myatt CA, Giblin JR, Davis RL, Rosenblum ML (1987) Distribution of extracellular matrix proteins in primary human brain tumors: an immunohistochemical analysis. Can J Neurol Sei 14:25-30
49. Rutka JT, Apodaca G, Stern R, Rosenblum M (1988) The extracellular matrix of the central and peripheral nervous systems: structure and function. J Neurosurg 69: 155-170
50. Sadik AR, Port R, Garfinkel B, Bravo J (1984) Extracranial metastasis of cerebral glioblastoma multiforme: case report. Neurosurg 15: 549-551
51. Salazar OM, Rubin P (1976) The spread of glioblastoma multiforme as a determining factor in the radiation treatment volume. Int J Radiat Oncol Biol Phys 1: 627-637
52. Scheid P (1938) Über Geschwulstbildung nach Schussverletzungen. Frankfurt Z Path 51:446-478
53. Scherer HJ (1940) The forms of growth in gliomas and their practical significance. Brain 63: 1-35
54. Smith DR, Hardman JM, Earle KM (1969) Metastasizing neuroectodermal tumors of the central nervous system. J Neurosurg 31:50-58
55. Stichel CC, Müller WH (1998) The CNS lesion scar: new vistas on an old regeneration barrier. Cell Tissue Res 294: 1-9
56. Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A, Dannenberg AJ (1999) Inhibition of cyclooxygenase-2 gene expression by p53. J Biol Chem 274:10911-10915
57. Valter MM, Hugel A, Huang HJ, Cavenee WK, Wiestier OD, Pietsch T, Wernert N (1999) Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-Iike tyrosine kinase-1 (Flt-l)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. Cancer Res 59: 5608-5614
58. Vertosick FT, Selker RG (1990) Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series. Neurosurg 27: 516-522
59. Wasylyk B, Hagman J, Gutierrez-Hartmann A (1998) Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem Sei 23:213-216
60. Wilkins RH, Odom GL (1966) Cytological changes in cere-brospinla fluid associated with resection of intracranial neoplasms. J Neurosurg 25:24-34
61. Yoshizato K, Zapf S, Westphal M et al (2002) Thromboxane synthase inhibitors induces apoptosis in migration arrested glioma cells. Neurosurgery 50: 343-354
62. Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH, Levine AJ (2000) Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 14: 981-993